Risk assessment before surgery for endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You have been diagnosed with endometrial cancer for the first time
- You are planning to have surgery as your main treatment
- Your cancer is at an early stage (stage I or II)
- You have a tumor sample available for testing
- You have not had chemotherapy or radiation before surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This trial uses a prediction model to better estimate the risk of endometrial cancer coming back. It aims to help doctors and patients make more personalized treatment decisions after surgery.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This trial looks at preventing the cancer from coming back after treatment for very low-risk endometrial (uterine) cancer. It studies a surgery approach that avoids removing lymph nodes, using scans and blood testing to choose the right patients.
This is a research study that looks at outcomes in women with endometrial (uterine) cancer who receive the usual standard surgery. Researchers will group patients based on the final surgical and pathology results and what additional (if any) treatment is recommended afterward.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.